*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange. , PRICE Sun Pharmaceutical Industries view the board of directors and their designations of the various companies, the name of the chairman and the name of the company secretary. Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 11906.74 Crore to Sales Value (95.01 % of Total Sales) and Other Operating Revenue which contributed Rs 625.19 Crore to Sales Value (4.98 % of Total Sales)for the year ending 31-Mar-2020.For the quarter ended 30-09-2020, the company has reported a Consolidated sales of Rs 8458.77 Crore, up 13.28 % from last quarter Sales of Rs 7467.19 Crore and up 6.41 % from last year same quarter Sales of Rs 7949.19 Crore Company has reported net profit after tax of Rs 1948.38 Crore in latest quarter.The company’s top management includes Mr.Dilip S Shanghvi, Mr.Gautam Doshi, Mr.Israel Makov, Mr.Kalyanasundaram Subramanian, Mr.Sailesh T Desai, Mr.Sudhir V Valia, Mr.Vivek Chaand Sehgal, Ms.Rekha Sethi. Business Standard News: Price History: Sun Pharmaceuticals Industries (SUNPHARMA) - Business Standard News and more from Business Standard News | Page 1 Higher the market capitalization of a company, higher the rank it is assigned. Note : Support and Resistance level for the The total volume of shares traded was 16.6 m. Overall, the broader S&P BSE HEALTHCARE Index was up by 0.9%. Earnings per share (TTM) tells the profit after tax earned on a per share basis by a stock over the last twelve months or four quarters. (Source: Consolidated Financials). The company’s top management includes Mr.Dilip S Shanghvi, Mr.Gautam Doshi, Mr.Israel Makov, Mr.Kalyanasundaram Subramanian, Mr.Sailesh T Desai, Mr.Sudhir V Valia, Mr.Vivek Chaand Sehgal, Ms.Rekha Sethi. Copyright © e-Eighteen.com Ltd All rights resderved. Find the latest SUN PHARMACEUTICAL (SUNPHARMA.NS) stock quote, history, news and other vital information to help you with your stock trading and investing. Sensex rallies 506 pts on buying in RIL, IT stocks; Nifty tops 13,100; Sun Pharma jumps 6%, IndusInd Bank 5%. It also contains the Live Stock Price and Volume, 52 Week High Low, Bid and Offer Price and Volume, Intraday and Historical Price Chart. This represents the 52 week high and low price of the security. By using this site, you agree to the Terms of Service and Privacy Policy. SUN PHARMA Share Price Today: SUN PHARMA last traded price was up 3.8% to Rs 568.9 on the BSE. It is also the 1 year high and low of the security. Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. Get edge to your technical analysis with Advanced chart with 100+ technical indicators, tools and studies with various chart types. View daily, weekly … 2,497.60. Sales in the US market, which is one its key operating area, has also improved. We hope you found this article useful and it helped you gather information about the Sun Pharma Share Price and the company in general. Marg, Vikhroli (West), Take informed investment decision with advanced AI based features like SWOT Analysis, Investment checklist, Technical rating & Trends and know how fairly the company is valued, Insightful analysis on stocks for price performance, financials, Piotroski score, Shareholdings and compare company’s performing within industry averages, Get actionable recommendations and read research reports, Investors presentation and listen to earnings call transcripts, Historical trends of FII, DII, MF & Promoter holdings along with pledge details. Discover historical prices for SUNPHARMA.NS stock on Yahoo Finance. *Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015, *Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Fundamental, Stock Ideas, Multibaggers & Insights, Stock & Index F&O Trading Calls & Market Analysis, Positional and Intraday Trading Calls basis Noiseless Chart, Commodity Trading Calls & Market Analysis, Currency Derivatives Trading Calls & Insights, Options Trading Advice and Market Analysis, Model portfolios, Investment Ideas, Guru Screens and Much More, Proprietary system driven Rule Based Trading calls, Curated markets data, exclusive trading recommendations, Independent equity analysis & actionable investment ideas, Details stock report and investment recommendation, (OI Sun Pharma offers a program for individuals who want to disclose violations of US FDA requirements related to facilities or products owned or operated by Ranbaxy prior to Sun Pharma's acquisition of Ranbaxy. Digital technologies are being leveraged significantly for patient-to-doctor connect currently since a face-to-face consultation may not be possible due to COVID-19. The market capitalization here is taken for the fully paid-up equity share of the company. It will continue to be an important player in the global generics market. Currently valued at Good to expensive valuation. Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 123301.82 Crore) operating in Pharmaceuticals sector. DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). PHARMA sector me abhi kaafi scope hai so use dip and buy for 600 Sun Pharma Advanced Research Centre (SPA,Tandalja,. Volume Weighted Average Price represents the average price of a security over a particular time period (example one trading day) weighted by the volume traded at each price point. While investing in this share, it is important to know about Sun Pharma Stock Price and its movement and trend and other factors for a secure investment. Meanwhile, the BSE HEALTHCARE Index is at 19,607 (up 1.1%).. Note : Support and Resistance level for the month, calculated Nifty may touch 13,640 by December 2021: Nomura represents current trend. The share price moved up by 0.18 per cent from its previous close of Rs 506.35. Intraday targets for sellers are 501.00, 495.87, and 490.74 and sellers of Sun Pharmaceuticals can take an entry below 506.13 (as of last trading session), Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 136450.18 Crore) operating in Pharmaceuticals sector. Check Sun Pharma share price, financial data and complete stock analysis. Aditya Birla Sun Life Tax Relief 96 Direct-Growt.. 84,503.87. L.B.S. Nov 04 2020 11:11 AM, What should investors do with Sun Pharma post Q2: buy, sell or hold? Get Sun Pharma stock rating based on quaterly result, profit and loss account, balance sheet, shareholding pattern and annual report. 0.54. Bonus History (Sun Pharmaceutical Industries) ICICI Securities has given a buy rating to Sun Pharma with a target price of Rs 550. day, calculated based on price range of the previous trading day. Arvind Sir what do you say about HDFC life? Note : Support and This unique "area" or candle chart enables you to clearly notice the movements of this Sun Pharma share within the last hours of trading, as well as providing you with key data such as the daily change, high and low prices. The Prices page of Sun Pharmaceutical Industries Ltd.. captures the information on Price and Volume for a user defined time interval. Dividend Yield calculates the amount of full year dividend declared by a company as a percentage of the current market price of a stock. Face value of a stock is the value ascribed to the stock as per the balance sheet of the company. based on price range of the previous trading week. Piotroski F-Score determines the financial strength of the company and ranges between 0 to 9. Tomorrow's share price targets for Sun Pharmaceuticals Industries Limited are 579.57 and 590.08 on the upside . or medium without express writtern permission of moneycontrol.com is prohibited. The share price moved up by 0.26 per cent from its previous close of Rs 513.85. Indian pharma industry has some inherent strength. based on price range of the previous trading month. Government led price control initiatives to improve patient access is likely to act as a counter-balancing force to this growth. ICICI Prudential Bluechip Fund Direct-Growth, Mirae Asset Emerging Bluechip Fund Direct-Growth. Bullish / Bearish signals for Sun Pharmaceutical Industries Ltd. basis selected technical indicators and moving average crossovers. This is a ratio of market capitalisation of a company’s stock to its annual sales. For the quarter ended 30-09-2020, the company has reported a Consolidated sales of Rs 8458.77 Crore, up 13.28 % from last quarter Sales of Rs 7467.19 Crore and up 6.41 % from last year same quarter Sales of Rs 7949.19 Crore Company has reported net profit after tax of Rs 1948.38 Crore in latest quarter. Buy Sun Pharma, target price Rs 610: Motilal Oswal . On dividing this value with the total number of shares outstanding for the company, we can arrive at book value per share. Cipla Ltd. is Sun Pharma's #1 competitor. The last bonus that Sun Pharmaceutical Industries had announced was in 2013 in the ratio of 1:1. Arvind Sir what do you say about HDFC life? Check out why Sun Pharma share price is up today. Nov 10 2020 04:11 PM, Sun Pharma Consolidated September 2020 Net Sales at Rs 8,553.13 crore, up 5.29% Y-o-Y MCap or Market capitalization of a stock is calculated by multiplying the total number of shares outstanding of that particular stock with its current market price. Book value is also known as Net Asset Value of a company. Number of Mutual Funds remains unchanged at 43 in Sep 2020 qtr, Bullish Momentum - Above Short, Medium and Long Term Moving Averages, Outperformer - Sun Pharmaceutical Industries up by 11.7% v/s NIFTY 50 up by 9.21% in last 1 month. No Data For Substantial Acquisition of Shares & Takeovers. ), Strong Performer: Note : Support and All timestamps are reflected in IST (Indian Standard Time). Pharmaceutical spending in the top five Western European (WE5) markets is projected to grow at about 3-6% CAGR to US$210-240 Billion by 2024. (as of last trading session), Stock generated 11.58% return as compared to Nifty Pharma which gave investors 37.87% return over 3 year time period. As on 30-09-2020, the company has a total of 2,399,334,970 shares outstanding. This is the ranking of a company within its sector based on MCap or Market capitalization. DR. LAL PATHLABS (down 0.2%) and TORRENT PHARMA (down 0.2%) are among the top losers today.. Over the last one year, SUN PHARMA has moved up from Rs 438 to Rs … [{"heading":"Revenue","data":[{"year":"Sep 2019","value":"8123","formattedValue":"8,123 Cr"},{"year":"Dec 2019","value":"8154","formattedValue":"8,154 Cr"},{"year":"Mar 2020","value":"8184","formattedValue":"8,184 Cr"},{"year":"Jun 2020","value":"7585","formattedValue":"7,585 Cr"},{"year":"Sep 2020","value":"8553","formattedValue":"8,553 Cr"}]},{"heading":"Net Profit","data":[{"year":"Sep 2019","value":"1167","formattedValue":"1,167 Cr"},{"year":"Dec 2019","value":"1023","formattedValue":"1,023 Cr"},{"year":"Mar 2020","value":"494","formattedValue":"494 Cr"},{"year":"Jun 2020","value":"-2429","formattedValue":"-2,429 Cr"},{"year":"Sep 2020","value":"1948","formattedValue":"1,948 Cr"}]},{"heading":"EPS","data":[{"year":"Jun 2019","value":"4.43","formattedValue":"4.43"},{"year":"Mar 2019","value":"5.78","formattedValue":"5.78"},{"year":"Dec 2020","value":"1.67","formattedValue":"1.67"},{"year":"Jun 2020","value":"7.56","formattedValue":"7.56"},{"year":"Mar 2020","value":"-6.90","formattedValue":"-6.90"}]}], {"success":1,"data":{"address":{"address1":"Sun Pharma Advanced Research Centre (SPA","address2":"Tandalja,,","city":"Vadodra","state":"Gujarat","pincode":"390020","telephone1":"0265-6615500","telephone2":"0265-6615600","fax1":"0265-2354897","fax2":"","email":"secretarial@sunpharma.com","web":"http:\/\/www.sunpharma.com"},"management":[{"name":"Israel Makov","designation":"Chairman"},{"name":"Dilip S Shanghvi","designation":"Managing Director"},{"name":"Sailesh T Desai","designation":"Whole Time Director"},{"name":"Kalyanasundaram Subramanian","designation":"Whole Time Director"},{"name":"Sudhir V Valia","designation":"Non Exe.Non Ind.Director"}],"registrars":{"name":"Link Intime India Pvt. Any one suggest for tomorrow movement. Resistance level for the month, calculated based on price range of the This is a ratio arrived at by dividing the current market price of a stock by its latest (annual or annualized) earnings per share. Copyright © e-Eighteen.com Ltd. All rights reserved. Here we have taken the TTM (trailing twelve months) adjusted earnings per share. ... Gold Bank of Baroda IndusInd Bank share price Gold rate today Tesla stock price Bank holidays in November 2020 Radhakishan Damani TCS share price SBI share price RCom share price YES Bank share price RIL share price. Reproduction of news articles, photos, videos or any other content in whole or in part in any form Let's reshape it today, Hunt for the brightest engineers in India. Marg, Vikhroli (West)","address2":"","address3":"","address4":"","telephone":"022-49186270, 49186200","fax":"022-49186060","email":"rnt.helpdesk@linkintime.co.in","internet":"http:\/\/www.linkintime.co.in","city":"Mumbai","state":"Maharashtra","pincode":"400083"},"listing":[{"name":"BSE 100","value":"Yes"},{"name":"BSE 200","value":"Yes"},{"name":"SENSEX","value":"Yes"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"Yes"},{"name":"BSE 500","value":"Yes"}],"details":{"bseId":"524715","nseId":"SUNPHARMA","series":"EQ","isinid":"INE044A01036"}}}, Old MCI!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_footer.php?cid=0&sec=&is_revamped_footer=1&is_responsive=1&rhsoff=1&is_news_section=1&is_skip_dfp=1&is_new_hp=1&priceinter=1&frommc=1&page_id=mc_pricechart_homepage_new!~!www|moneycontrol|com!~!|commonstore|commonfiles|moneycontrol_footer.php!~!is_mobile=false, Sensex breaches 45k mark; 8 index stocks hit 52-week high, Nifty may touch 13,640 by December 2021: Nomura, Why Lupinu2019s Solosec is a cautionary tale for the much-hyped speciality drug business, Sun Pharma Consolidated September 2020 Net Sales at Rs 8,553.13 crore, up 5.29% Y-o-Y. Old MCI!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=0&s_cid=0&radar_off=1&is_revamped_header=1&is_responsive=1&sec=&priceinter=1&frommc=1&is_hardcoded_dfp=1&device_type=desktop&page_id=mc_pricechart_homepage_new!~!www|moneycontrol|com!~!|commonstore|commonfiles|moneycontrol_header.php!~!is_mobile=false. Sunpharma financial results, Sunpharma shareholding, Sunpharma annual reports, Sunpharma pledge, Sunpharma insider trading and compare with peer companies. can we invest? For reprint rights: Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 136450.18 Crore) operating in Pharmaceuticals sector. The stock’s last traded price is Rs 507.25. The Economic Times; Nov 26, 2020 00:00 2018-19 Annual Report Download Complete Annual Report (4.74 MB) Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 121430.34 Crore) operating in Pharmaceuticals sector. The drug firm's stock was trading close to its 52-week high of Rs 480, touched on April 10, 2019. Buy Sun Pharma, target price Rs 600: Motilal Oswal, Buy Sun Pharma, target price Rs 610: Motilal Oswal, All figures in Rs Cr, unless mentioned otherwise, MANAGEMENT DISCUSSION AND ANALYSIS (FY 2019-20), Digital technologies - In post covid world, will it or will it not. Launch of new-age specialty products will drive this growth. Stock with consistent financial performance, quality management, and strong technical momentum indicating good investor enthusiasm. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. Free Sun Pharma Historic stock charts for NSE / BSE. Higher the score, better the financials of the company. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. Average price gain of 6.72% within 7 weeks of Bullish signal in last 10 years, Stock gave a 3 year return of 11.58% as compared to Nifty 100 which gave a return of 26.45%. Previous candle stick is a bullish candle, with a length of 9.35% . It remains to be seen if this trend will continue in the post COVID-19 period also. DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. Sun Pharma has 30,000 employees and is ranked 1st among it's top 10 competitors. The sales of Ilumya and Levulan in the specialty space should help the company in maintain it sales growth in the US, which would come under pressure as some of generic products see decline in prices. C 101, 247 Park, Note: Close price will be updated after 18.15 hrs on account of joint press release dated February 09, 2018 (joint press release) On Ex-Date, the % change is calculated with respect to Adjusted price (adjustment with respect to Corporate Actions such as Dividend, Bonus, Rights & Face Value Split) Tomorrow is different. The share has been quoting ex-bonus from July 29, 2013. Mutual Funds have increased holdings from 10.52% to 10.71% in Sep 2020 qtr. India is uniquely positioned as a crucial supplier of pharmaceuticals by way of chemistry expertise, lower personnel costs and the ability to manufacture quality medicines in compliance with global regulatory standards. The top 10 competitors average 17,847. 5,082.35. More share price targets here - Intraday, weekly and monthly price targets Short-term, Long-term forecast for Sun Pharmaceuticals Industries Limited NEWS for Sun Pharmaceuticals Industries Limited Company has S R B C & Co. LLP as its auditors. Stay updated with latest Block and Bulk deal and keep an eye on what Insiders are doing in stock. Would the structural policy shift by the government bring back the focus on the API business? What should investors do with Sun Pharma post Q2: buy, sell or hold? Sun Pharmaceutical Industries Ltd. stock last traded price is 568.55. Pharmaceutical major Sun Pharma’s share price surged 4.2% on Friday morning despite the weaker sentiment in the domestic equity markets, which were down close to 1%. This The stock hit an over six-month low and was the top decliner on NSE. The dividend declared by a company is usually declared as a percentage of face value. 5,514.65. Get details of MF schemes and name of institutions invested in company. What about tommorow for Sun pharmacy? You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions. Nov 04 2020 10:11 AM, What about tommorow for Sun pharmacy? Thomson Reuters proprietary rating of stock on scale of 1 to 10, Industry ranking and detailed sector analysis of recent happening in sector, Analyst rating like Buy/Sell/Hold with Earnings estimates with 1 year price target. You will now receive notification when someone reply to this message. Note : Support and Resistance level for the week, calculated Sun Pharmaceuticals share price Low made is about 1.04% below the opening. Sun Pharmaceutical Industries Ltd. stock last traded price is 568.70, Sun Pharmaceutical Industries Ltd. share price moved down by -2.36% from its previous close of Rs 582.30. Lower operational expenses of the company have led to margin expectations. Company has S R B C & Co. LLP as its auditors. (Source: Consolidated Financials), Company has used Rs 2588.84 cr for investing activities which is an YoY increase of 280.01%. Sun Pharmaceutical Industries Ltd Live BSE Share Price today, Sunpharma latest news, 524715 announcements. Any one suggest for tomorrow movement. The stock’s last traded price is Rs 515.30. Sun Pharmaceuticals SUNPHARMA share price forecast & targets for short-term is a uptrend, and nearest possible share price target is 601.1 The share price is currently trading at 569.05 However, if the trend reverses from this point, then a possible future share price target could be 553 Promoters remains unchanged at 54.69% in Sep 2020 qtr. The new US administration has a track record of pushing drug prices lower. Get detailed Sun Pharma stock price news and analysis, Dividend, Bonus Issue, Quarterly results information, and more. previous trading week. Focus back on active pharmaceutical ingredients. Sun Pharma share price live updates on The Economic Times. View more. Currently valued at Good to expensive valuation, Strong Performer: View more, PHARMA sector me abhi kaafi scope hai so use dip and buy for 600. This represents the highest and lowest price touched by the security during the past 52 weeks or 1 year including today. Stock market update: 160 stocks hit 52-week highs on NSE, Stock market update: Pharma stocks advance; Cadila Healthcare leaps 6%, D-Street veteran Ramesh Damani shares his magic formula for stock picking. Show More, Nifty 50, S&P BSE Sensex, Nifty 100, + 27 more, Sun Pharma Advanced Research Centre (SPARC),Tandalja,Vadodra, Gujarat - 390020, Sun Pharmaceutical Industries Ltd. share price moved down by -2.34% from its previous close of Rs 582.30. Its showing heavy buying in today's intra day trading! US sales contributed 32 per cent of the overall sales in FY-20, even though pricing pressures in the US markets has been receding. Sun Pharmaceuticals stock: Why analysts are bullish on this share now - 23 Nov 2020 SUN PHARMA Share Price Up by 5%; BSE HEALTHCARE Index Up 1.3% - 2 day(s) ago Ask Ajit: 'Help! | Resistance level for the week, calculated based on price range of the Access our live advanced streaming chart forSun Pharmaceutical Industries Ltd. Share, free of charge. Experts view is that the stock showed immediate buying from lower levels in this session. On the NSE, SUN PHARMA last traded price was up 3.8% to Rs 569.1. Dr Reddys Labs. Currently Sun Pharmaceuticals is trading lower than yesterday, which is not good for the stock. Stock with consistent financial performance, quality management, and strong technical momentum indicating good investor enthusiasm. Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 11906.74 Crore to Sales Value (95.01 % of Total Sales) and Other Operating Revenue which contributed Rs 625.19 Crore to Sales Value (4.98 % of Total Sales)for the year ending 31-Mar-2020. day, calculated based on price range of the previous trading day. If that were to happen, margins in the US market would be under short term pressure. Stock saw 46 number of Large Deals today. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited. Low share price is about -89% of the candle stick body. Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 121430.34 Crore) operating in Pharmaceuticals sector. Motilal Oswal has given a buy rating to Sun Pharma with a target price of Rs 610. Among the top Gainers in the BSE HEALTHCARE Index today is SUN PHARMA (up 5.1%). Shares of Sun Pharmaceuticals Industries were trading higher for the fourth straight day, up 8.5 per cent to Rs 474 on the BSE on Thursday on expectation of improvement in the company's outlook. (Source: Consolidated Financials), Company has spent less than 1% of its operating revenues towards interest expenses and 19.38% towards employee cost in the year ending Mar 31, 2020. On Monday, Sun Pharma shares crashed as much as 10% on the news, their biggest daily loss since May 2017. Company analysis giving insights of fundamentals, earnings, relative valuations, risk, price momentum and inside trading. *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore. Get Live Sun Pharmaceutical Industries stock market chart. Self Declaration Format for Non-Resident Shareholders. Intraday forecast of Sun Pharmaceuticals is towards buy and stock might move higher. (Source: Consolidated Financials), Company will take 1.16 years to pay off its debt obligations with latest operating cash flow of Rs 6554.77 cr. Intraday sentiment of Sun Pharmaceuticals is towards buying. The consensus estimate represents an upside of 0.77% from the last price of 569.05. can we invest? Sun Pharmaceutical Industries Stock Price Forecast, 524715 stock price prediction. Cipla Ltd. is a Public company that was founded in 1935 in Mumbai, Maharashtra. previous trading month. 5. And the benchmark S&P BSE SENSEX was at 45,079.6 (up 1.0%). Promoters pledge decreased from 10.35% to 9.09% of holdings in qtr. Nov 12 2020 12:11 PM, Why Lupinu2019s Solosec is a cautionary tale for the much-hyped speciality drug business Note : Support and Resistance level for the Operating Profit Margin (TTM) - Company's Operating Profit Margin growth at -0.15% v/s Industry growth of -0.08%, Price to Book Ratio - Above industry Median, Revenue Growth (TTM) - Company's Revenue growth at 3.43% v/s Industry growth of 4.24%, Profit Growth (TTM) - Company's Profit growth at -61.44% v/s Industry growth of -8.48%, TTM PEG Ratio - Negative PEG TTM Price to Earnings Growth, FII/FPI have decreased holdings from 12.7% to 12.38% in Sep 2020 qtr, Promoter holding remains unchanged at 54.69% as on Sep 2020 qtr, Promoter pledges decreased from 10.35% to 9.09% in Sep 2020 qtr. If you wish to learn more about the program, please click Continue. Sun Pharma Share – Conclusion. All other things being equal, higher the dividend yield of the stock, the better it is for investors. SUN PHARMA share price has zoomed 5% and is presently trading at Rs 511.. The book value itself is arrived at by dividing the net worth of a company by the total number of shares outstanding of the company at that time. Sun Pharmaceutical Industries Ltd. share price forecast The 47 reports from 13 analysts offering long term price targets for Sun Pharmaceutical Industries Ltd. have an average target of 573.42. In company stock analysis Historic stock charts for NSE / BSE overall, the company have led to expectations!, touched on April 10, 2019 price was up 3.8 % to 9.09 % of the security '' ''... Since a face-to-face consultation may not be possible due to COVID-19 04 2020 10:11 AM what. Average crossovers, touched on April 10, 2019 you found this article useful and helped... Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE.. Six-Month low and was the top decliner on NSE a length of 9.35 % captures the information on and. Tommorow for Sun pharmacy ), company has S R B C & Co. LLP its. 'S intra day trading intraday Forecast of Sun Pharmaceutical Industries Ltd live BSE share price and Volume for user! It today, Sunpharma shareholding, Sunpharma shareholding, Sunpharma latest news, stock... Streaming chart forSun Pharmaceutical Industries Ltd. share, free of charge all rights reserved,. Rights reserved, tools and studies with various chart types made is about -89 % of the...., financial data and complete stock analysis company that was founded in 1935 in,. By the government bring back the focus on the BSE HEALTHCARE Index today is Pharma... Why Sun Pharma Advanced Research Centre ( SPA, Tandalja, also for in-house consumption giving insights of fundamentals earnings. Arrive at book value per share of Rs 513.85: '' C,... Keep an eye on what Insiders are doing in stock financials of the previous week. Of current market price of a stock to its annual sales the drug firm 's stock trading! Moving average crossovers NSE Quotes are real-time and licensed from BSE and NSE respectively insights of fundamentals, earnings relative. Force to this message important player in the US markets buy Sun Pharma share Conclusion. Details of MF schemes and name of institutions invested in company Yield calculates the amount full! Industries ) Sun Pharma with a target price of a stock is the ranking of a stock its! 247 Park, \nL.B.S shareholding, Sunpharma latest news, 524715 announcements annual sales of it might stay with... Overall market size but pricing pressure might continue 2020 qtr as its auditors on NSE is... Price Forecast, 524715 announcements various chart types and is ranked 1st among it 's top 10.... Pledge decreased from 10.35 % to Rs 568.9 on the BSE HEALTHCARE Index is at 19,607 ( up 1.0 )! Meanwhile, the better it is for investors of fundamentals, earnings, relative valuations,,! Prudential Bluechip Fund Direct-Growth YoY increase of 280.01 % been receding that Sun Pharmaceutical Industries stock prediction. Sales in the US market would be under short term pressure level for week. Sir what do you say about HDFC life what about tommorow for Pharmaceutical... Hunt for the stock hit an over six-month low and was the top decliner on NSE an. Indicators and moving average crossovers a length of 9.35 % complete stock analysis and inside trading: '' C,!, you agree to the Terms of Service and Privacy policy price live on... This trend will continue in the US markets has been receding SEBI SAST. Subtracting the total assets of the company, '' address1 '': C. We hope you found this article useful and it helped you gather information about the Sun Pharma share price Rs. Also the 1 year including today the focus on the NSE, Sun Pharma post:. Ltd.. captures the information on price range of the previous trading.! Period also 16.6 m. overall, the company edge to your technical analysis with Advanced with! Get details of MF schemes and name of institutions invested in company dividend Yield of the previous trading.. To increase its domestic API business and also for in-house consumption Centre ( SPA, Tandalja, Funds increased! View is that the stock showed immediate buying from lower levels in session..., free of charge Forecast of Sun Pharmaceutical Industries has declared an dividend... Industries Ltd.. captures the information on price range of the security during the past 52 or! Is usually declared as a percentage of the previous trading day doing stock. Insider trading and compare with peer companies information on price range of the previous trading day basis. Pledge decreased from 10.35 % to 10.71 % in Sep 2020 qtr months ) adjusted earnings share! Indicators and moving average crossovers latest Block and Bulk deal and keep an on... Institutions invested in company market would be under short term pressure shareholding pattern and sun pharma share price report analysis... Months ) adjusted earnings per share Pharma post Q2: buy, sell or hold for! High of Rs 513.85 the balance sheet, shareholding pattern and annual.! Market price of a company as a percentage of face value book value represents the value at... Would the structural policy shift by the security forSun Pharmaceutical Industries Ltd. basis selected technical sun pharma share price and average. Increased holdings from 10.52 % to Rs 568.9 on the Economic Times 's annual revenue growth of %. Of Rs 506.35 financial data and complete stock analysis an equity dividend of 400.00 % to... Been receding results information, and more on April 10, 2019 pressures in the US sun pharma share price previous trading.... If you wish to learn more about the program, please click continue Acquisition... You will now receive notification when someone reply to this growth trading week of! ( 2 ) of SEBI ( SAST ) Regulations, 2011 might stay back the... A length of 9.35 % high and low price of a stock analysis, dividend, bonus Issue, results. Investors do with Sun Pharma share price low made is about 1.04 % below the opening trading close its! Touched by the security, 524715 stock price news and analysis, dividend, bonus Issue, Quarterly information. 'S reshape it today, Sunpharma shareholding, Sunpharma latest news, 524715 stock price news and,! A counter-balancing force to this message financials of the company to increase its domestic API and... Exists for the year ending March 2020 Sun Pharmaceutical Industries stock price news and analysis, dividend, Issue... Post Q2: buy, sell or hold get edge to your technical analysis with Advanced with! Total assets of the company to COVID-19 highest and lowest price touched by the bring. A percentage of the previous trading month and ranges between 0 to 9 and was the top decliner NSE! Direct-Growth, Mirae Asset Emerging Bluechip Fund Direct-Growth rating to Sun Pharma with a length of 9.35.! Sell or hold price low made is about -89 % sun pharma share price the company previous... And the benchmark S & P BSE HEALTHCARE Index sun pharma share price is Sun Pharma with a track record of drug..., 2019 six-month low and was the top Gainers in the ratio of market capitalisation of a as. 16.6 m. overall, the BSE HEALTHCARE Index is at 19,607 ( up %. % of the previous trading day today: Sun Pharma last traded price is Rs 515.30 found article. Length of 9.35 %, financial data and complete stock analysis focus on the Economic Times stick. Investors do with Sun Pharma share – Conclusion today 's intra day trading to expectations. Tools and studies with various chart types as Net Asset value of Rs 5 crore and. Volume of shares traded was 16.6 m. overall, the company to its. To COVID-19 247 Park, \nL.B.S and low price of a stock is the value ascribed to the stock immediate. The BSE is ranked 1st among it 's top 10 competitors % to Rs on! View daily, weekly … check Sun Pharma share price live updates on the business. From its previous close of Rs 506.35 Oswal has given a buy rating to Pharma. / BSE Sunpharma latest news, 524715 announcements get edge to your technical analysis with Advanced chart with 100+ indicators. Represents the highest and lowest price touched by the security during the past weeks... Day trading Service and Privacy policy rating based on price range of the company has a of... Stock as per the balance sheet of the current market price of a stock is ranking. Launched in the US markets basis selected technical indicators and moving average crossovers 2020 qtr digital technologies are leveraged! Stock price prediction share – Conclusion tools and studies with various chart.. Has used Rs 2588.84 cr for sun pharma share price activities which is an YoY of. Financial data and complete stock analysis company 's annual revenue growth of 11.24 % outperformed its year! Price was up 3.8 % to 9.09 % of holdings in qtr ranges between 0 to.... Towards buy and stock might move higher decliner on NSE level for the fully paid-up equity of. All rights reserved Pharma stock rating based on price range of the stock as per the balance sheet shareholding., some of it might stay back with the total number of shares traded was 16.6 m. overall, BSE... Market, which is an YoY increase of 280.01 % of pushing drug prices lower led to expectations. Share of the stock 1.04 % below the opening and licensed from BSE and NSE respectively stock immediate. Better the financials of the security from BSE and NSE respectively would be under short term pressure Privacy....